Retatrutide (CAS 2381089-83-2) is a triple-agonist peptide that engages three receptors simultaneously the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon receptor making it one of the most-studied multi-receptor metabolic peptides currently in the research literature
Mood changes such as irritability or feeling low are also common, as well as tingling sensations in the hands and feet that signal nerve involvement
there was a 32% reduction in the number of patients inappropriately receiving B-12 (521 to 352) , and the proportion of patients receiving B-12 at the correct frequency rose from 58% to 72%
For patients with diabetes, monitoring for retinopathy is important, as rapid improvement in glycemic control with GLP-1 receptor agonists has been associated with temporary worsening of diabetic retinopathy in some cases
As a pediatric ICU nurse, nurse practitioner, and clinical faculty member at some of the countrys most respected institutions, including Childrens Healthcare of Atlanta and Johns Hopkins, she lived and breathed evidence-based medicine, patient safety, and quality improvement
